Project IVAC-ALL-1

Basic data

Title:
IVAC-ALL-1
Duration:
01/10/2016 to 31/12/2018
Abstract / short description:
Prospective phase I/II study: Patient-individualized peptide vaccination based on whole exome sequencing with adjuvant GM-CSF in children with relapsed acute lymphoblastic leukemia
Keywords:
adjuvant GM-CSF
children
Kinder
leukemia
Leukämie
peptide vaccination
relapsed acute lymphoblastic leukemia
patient-individualized

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes
Faculty of Medicine

Funders

Heidelberg, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.